July 6 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS :
* LICENSING DEAL WITH SEQIRUS FOR INVESTIGATIONAL SEASONAL ALLERGIC RHINITIS NASAL SPRAY FOR AUSTRALIA AND NEW ZEALAND
* GLENMARK TO BE RESPONSIBLE FOR PRODUCT SUPPLY AND SEQIRUS FOR REGULATORY FILING AND COMMERCIALIZATION
* GLENMARK WILL RECEIVE AN UPFRONT PAYMENT AS WELL AS REGULATORY AND COMMERCIAL MILESTONE PAYMENTS FROM SEQIRUS